• Applying a Constrained Optimization Portfolio Model to Aid Prioritization of Public Health Interventions in Malaysia

    May 1, 2020, 00:00

  • Survey on Willingness to Pay for Life-Saving Treatment, Functional Recovery, and Cosmesis in a Neuroscience Outpatient Clinic Setting in Singapore [Editor's Choice]

    May 1, 2020, 00:00

  • Association of Socioeconomic Status With Childhood Anemia Among Infant, Toddler, and Preschool Children in Bangladesh

    May 1, 2020, 00:00

  • The Development of Health Technology Assessment in Asia: Current Status and Future Trends [Editor's Choice]

    May 1, 2020, 00:00

  • Table of Contents

    May 1, 2020, 00:00

  • Population Aging, Technological Innovation, and the Growth of Health Expenditure: Evidence From Patients With Type 2 Diabetes in Taiwan

    May 1, 2020, 00:00

  • The Factors Associated With Direct Medical Costs in Patients With Gastric Cancer: Quantile Regression Approach Compared With Gamma Regression

    May 1, 2020, 00:00

  • Cost-Effectiveness of Transcatheter Aortic Valve Implantation Using a Balloon-Expandable Valve in Japan: Experience From the Japanese Pilot Health Technology Assessment

    May 1, 2020, 00:00

  • The Structure and Parameterization of the Breast Cancer Transition Model Among Chinese Women

    May 1, 2020, 00:00

  • Cross-Cultural Adaptation and Psychometric Analysis of the Persian Version of the ICEpop CAPability Measure for Adults Capability Measure in the Iranian General Population

    May 1, 2020, 00:00

  • Use of Reimbursed Psychology Videoconference Services in Australia: An Investigation Using Administrative Data

    May 1, 2020, 00:00

  • Relationships Between Pharmaceutical Therapy–Related Quality of Life and Health Utility Scores in Thai Patients With Chronic Diseases

    May 1, 2020, 00:00

  • Economic Evaluation of Breast Cancer Early Detection Strategies in Asia: A Systematic Review [Editor's Choice]

    May 1, 2020, 00:00

  • The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals

    May 1, 2020, 00:00

  • Complicated Issues of Medical Examination: A Case Study of the Irkutsk Region

    May 1, 2020, 00:00

  • Tackling the 3 Big Challenges Confronting Health Technology Assessment Development in Asia: A Commentary

    May 1, 2020, 00:00

  • Causes of Under-5 Mortality Among Brazil, the Russian Federation, India, China, and South Africa Nations: A Comparative Study

    May 1, 2020, 00:00

  • Editorial Board

    May 1, 2020, 00:00

  • Inappropriate Rate of Admission and Hospitalization in the Iranian Hospitals: A Systematic Review and Meta-Analysis

    May 1, 2020, 00:00

  • Translation, Cultural Adaptation, and Validation of Short-Form 6D on the General Population in Indonesia

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Prostate-Specific Antigen Screening Among Chinese Men

    May 1, 2020, 00:00

  • The Economic Burden of Candidemia and Invasive Candidiasis: A Systematic Review

    May 1, 2020, 00:00

  • Long Term Cost-Effectiveness of a Systolic Blood Pressure Goal of <120 mmHg in Hypertensive Patients Without Diabetes Mellitus

    May 1, 2020, 00:00

  • The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia’s Social Health Insurance System [Editor's Choice]

    May 1, 2020, 00:00

  • Comparative Analysis of Prescription Drug Prices in South Asian Association for Regional Cooperation Countries

    May 1, 2020, 00:00

  • Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand

    May 1, 2020, 00:00

  • Determining the Cost and Length of Stay at Intensive Care Units and the Factors Influencing Them in a Teaching Hospital in Malaysia

    May 1, 2020, 00:00

  • Copyright/Subscription

    Dec 16, 2019, 08:54

  • Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean Perspective

    Dec 1, 2019, 00:00

  • Determining the Operating Costs of a Medical Surveillance Program for Copper Miners Exposed to High Altitude–Induced Chronic Intermittent Hypoxia in Chile Using a Combination of Microcosting and Time-Driven Activity-Based Costing

    Dec 1, 2019, 00:00

  • Response to Letter to the Editor

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of a Technology-Enhanced Diabetes Care Management Program in Mexico

    Dec 1, 2019, 00:00

  • Editorial Board

    Dec 1, 2019, 00:00

  • The Brazilian Portuguese Version of the DISCERN Instrument: Translation Procedures and Psychometric Properties

    Dec 1, 2019, 00:00

  • Burden of Disease Attributable to Obesity and Overweight in Colombia

    Dec 1, 2019, 00:00

  • Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective

    Dec 1, 2019, 00:00

  • Inflammatory Bowel Disease in Latin America: A Systematic Review

    Dec 1, 2019, 00:00

  • The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico [Editor's Choice]

    Dec 1, 2019, 00:00

  • Economic Cost of Severe Acute Respiratory Infection Associated to Influenza in Colombian Children: A Single Setting Analysis

    Dec 1, 2019, 00:00

  • The Price of Substitute Technologies

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia

    Dec 1, 2019, 00:00

  • Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology “Ignacio Chávez”

    Dec 1, 2019, 00:00

  • The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia [Editor's Choice]

    Dec 1, 2019, 00:00

  • A Comparison of UK and Brazilian SF-6D Preference Weights When Applied to a Brazilian Urban Population [Editor's Choice]

    Dec 1, 2019, 00:00

  • Custo-utilidade de terapias-alvo comparadas à dacarbazina para o tratamento de primeira linha do melanoma avançado não-cirúrgico e metastático no Sistema Único de Saúde do Brazil

    Dec 1, 2019, 00:00

  • Agnet y Judicialization en Salud en Argentina

    Dec 1, 2019, 00:00

  • Prevalence of Symptoms and Symptom Clusters of Patients on Dialysis in Uruguay

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Nonsurgical Treatment in People With Obesity and Comorbidity in Colombia

    Dec 1, 2019, 00:00

  • Acuerdos de Riesgo Compartido: Lecciones Para su Diseño e Implementación a la Luz de la Experiencia Internacional

    Dec 1, 2019, 00:00

  • Beneficio económico de los ensayos clínicos controlados patrocinados: El gasto evitable en medicamentos para el tratamiento de la artritis reumatoidea

    Dec 1, 2019, 00:00

  • Health Economics and Outcomes Research Knowledge Needs Assessment for Latin America [Editor's Choice]

    Dec 1, 2019, 00:00

  • Table of Contents

    Dec 1, 2019, 00:00

  • Costo de la intoxicación por Paraquat en Colombia

    Dec 1, 2019, 00:00

  • Challenges in the Regulation of High-Cost Treatments: An Overview From Brazil [Editor's Choice]

    Dec 1, 2019, 00:00

  • Budget Impact of Cryoablation Versus Radiofrequency Ablation of Atrial Fibrillation in the Brazilian Public Healthcare System

    Dec 1, 2019, 00:00

  • The Cost-Effectiveness of Continuous Versus Intermittent Renal Replacement Therapies in Acute Kidney Injury: Perspective of the Social Services for the Elderly in Argentina

    Dec 1, 2019, 00:00

  • New Challenges in Oncology for the Brazilian Private Health Sector: Specialists' Concerns After the ISPOR International Congress in Boston, Massachusetts, 2017

    Dec 1, 2019, 00:00

  • Epidemiología, consumo de recursos y costos del manejo médico de la Hepatitis C en Argentina, Colombia, Uruguay y Venezuela

    Dec 1, 2019, 00:00

  • Budgetary Impact of Oral Rehabilitation With Complete Dentures: An Economical Evaluation From São Paulo State, Brazil

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Proton Versus Photon Therapy in Pediatric Medulloblastoma Treatment: A Patient Volume–Based Analysis

    Dec 1, 2019, 00:00

  • PMU4 ESTIMATING THE ECONOMIC BURDEN OF DISEASE FROM WATER, SANITATION AND HYGIENE IN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN53 EXAMINATION OF PATIENT DELAY AMONG PATIENTS DIAGNOSED WITH PROSTATE CANCER

    Oct 1, 2019, 00:00

  • PBI5 COST OF ADVERSE EVENTS ASSOCIATED WITH TREATMENT WITH BIOLOGICAL DRUGS IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS IN ARGENTINA

    Oct 1, 2019, 00:00

  • PDB12 BUDGET IMPACT ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN TYPE 1 DIABETES MELLITUS COMPARED WITH MULTIPLE DAILY INJECTIONS IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • RE4 PROPOSED SOLUTIONS TO ACHIEVING HEALTHCARE SUSTAINABILITY IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PSY9 PATRONES DE TRATAMIENTO FARMACOLOGICO EN PACIENTES ADULTOS CON DERMATITIS ATOPICA

    Oct 1, 2019, 00:00

  • PNS4 TRENDS FOR INTRODUCTION OF APPROVED DRUGS IN NETWORK META-ANALYSIS

    Oct 1, 2019, 00:00

  • HI3 EVIDENCIA DE LA VIDA REAL EN ARGENTINA: TRATAMIENTO DE PACIENTES CON HEPATITIS C EN EL SISTEMA DE TUTELAJE DE TECNOLOGIAS SANITARIAS EMERGENTES (STTSE)

    Oct 1, 2019, 00:00

  • PMS16 COMPARING QUALITY OF LIFE, SYMPTOMS, AND TREATMENT PATTERNS OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS: FINDINGS FROM A GLOBAL SURVEY

    Oct 1, 2019, 00:00

  • PNS9 BUDGET IMPACT OF NEW RECOMMENDATION FOR ATROPINIZATION IN BRAZILIAN GUIDELINES FOR ANTICOLINESTARASIS INTOXICATION

    Oct 1, 2019, 00:00

  • PCN7 COSTOS DE LOS EVENTOS ADVERSOS ASOCIADOS CON EL TRATAMIENTO DEL MIELOMA MULTIPLE REFRACTARIO RECIDIVANTE (MMRR) EN ARGENTINA

    Oct 1, 2019, 00:00

  • PIH9 IMPACTO ECONOMICO DE ANEMIA Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • EP4 HOW IS SELF-PERCEIVED HEALTH STATUS (EQ-5D) ASSOCIATED WITH SOCIOECONOMIC CONDITIONS IN 22 LATIN AMERICAN COUNTRIES?

    Oct 1, 2019, 00:00

  • PIT7 THE PROFILE OF FIREARMS INJURIES IN BRAZIL BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PNS29 CHANGING OF HEALTH CARE TOURISM AND ITS RECOVERING ROLE FOR ECONOMY

    Oct 1, 2019, 00:00

  • PDG16 ACESSO A INFORMAÇÕES E SERVIÇOS PRESTADOS PELA SUPERINTENDÊNCIA DE ASSISTÊNCIA FARMACÊUTICA DO ESTADO DE MINAS GERAIS POR MEIO DO APLICATIVO MGAPP

    Oct 1, 2019, 00:00

  • PRS9 ESTIMATIVA DO CUSTO DA ASMA EM UM PLANO DE SAUDE NO BRASIL - ESTUDO DE MUNDO REAL

    Oct 1, 2019, 00:00

  • PIH15 CURRENT PANORAMA OF THE SURGICAL TREATMENT OF ENDOMETRIOSIS BY THE BRAZILIAN PUBLIC SYSTEM

    Oct 1, 2019, 00:00

  • PNS31 A VIA ADMINISTRATIVA COMO UMA ALTERNATIVA DE ACESSO AO MEDICAMENTO NO SISTEMA ÚNICO DE SAÚDE: SOLUÇÃO OU PROBLEMA?

    Oct 1, 2019, 00:00

  • PMD8 COST-EFFECTIVENESS OF THERMOABLATION VERSUS SURGERY FOR TREATMENT OF LIVER METASTASIS

    Oct 1, 2019, 00:00

  • PCN29 TENDENCIAS EN LA MORTALIDAD DEL CANCER DE MAMA EN COLOMBIA EN MUJERES MAYORES DE 60 AÑOS

    Oct 1, 2019, 00:00

  • PDG9 EVALUACIÓN PARA LA SELECCIÓN DE PRECIO MÁXIMO DE VENTA DE MEDICAMENTOS

    Oct 1, 2019, 00:00

  • PBI11 ESTUDIOS DE SINTESIS Y TOMA DE DECISIONES: A PROPOSITO DE LA CONTINUACION DEL TRATAMIENTO CON UN BIOSIMILAR EN PACIENTES QUE RECIBEN INFLIXIMAB EN EL SEGURO SOCIAL EN SALUD EN PERU

    Oct 1, 2019, 00:00

  • PRO12 LITERATURE REVIEW OF CHALLENGES AND OPPORTUNITIES IN HEALTH ECONOMIC EVALUATION METHODOLOGY IN RARE DISEASES

    Oct 1, 2019, 00:00

  • PSY6 HUMANISTIC AND ECONOMIC BURDEN OF DISEASE FOR PSORIASIS IN ARGENTINA, BRAZIL, COLOMBIA AND MEXICO

    Oct 1, 2019, 00:00

  • PNS50 ANALISIS DE IMPACTO DE LA IMPLEMENTACION DE UNA RED INTEGRADA MEDIANTE LA MEDIDA DE CALIDAD DE VIDA RELACIONADA CON LA SALUD EN POBLACION COLOMBIANA

    Oct 1, 2019, 00:00

  • PCV13 EFECTIVIDAD DEL CATETER VENOSO DE INSERCION CENTRAL VS EL CATETER VENOSO CENTRAL DE INSERCION PERIFERICA EN EL TRATAMIENTO DE PACIENTES EN LA UNIDAD DE CUIDADOS INTENSIVOS.

    Oct 1, 2019, 00:00

  • PCN63 COSTOS ASOCIADOS AL MANEJO DE PACIENTES CON CARCINOMA HEPATOCELULAR EN EL REGIMEN CONTRIBUTIVO

    Oct 1, 2019, 00:00

  • PBI7 CASE STUDY: ECONOMICAL ANALYSIS OF WASTE IN BIOLOGICAL PRODUCTS IN AN INSTITUTION IN COLOMBIA

    Oct 1, 2019, 00:00

  • CE3 ECONOMIC EVALUATION OF THE USE OF PRE-FILLED SYRINGE VERSUS MANUALLY FILLED SYRINGE PARAFLUSHING IN PATIENTS WITH CENTRAL VENOUS CATHETER IN THE PERSPECTIVE OF HEALTH CAREERS

    Oct 1, 2019, 00:00

  • PIH19 CONTRASTE DE MODELOS DE PROBABILIDAD DICOTOMICOS PARA LA ESTIMACION DE PARTOS Y CESAREAS EN UNA ENTIDAD PROMOTORA DE SALUD COLOMBIANA

    Oct 1, 2019, 00:00

  • MT3 ICD THERAPY FOR SUDDEN CARDIAC ARREST PREVENTION IS POTENTIALLY COST-EFFECTIVE IN THE 1.5 PRIMARY PREVENTION POPULATION IN COLOMBIA: AN ECONOMIC EVALUATION OF THE IMPROVED SCA STUDY

    Oct 1, 2019, 00:00

  • PDB7 COST COMPARISON OF BOVINE PERICARDIUM (BP) VS. BIOCOMPATIBLE GLYCOLIDE COPOLYMER BUTTRESS IN GASTRIC STAPLE LINE REINFORCEMENT (SLR)

    Oct 1, 2019, 00:00

  • PGI3 IMPACT OF DOSE ESCALATION ON TREATMENT COST OF IMMUNOBIOLOGICAL THERAPIES FOR CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

    Oct 1, 2019, 00:00

  • PMD1 PATIENT OUTCOMES IN CENTRIFUGE AND MEMBRANE THERAPEUTIC PLASMA EXCHANGE (TPE): LITERATURE REVIEW WITH A FOCUS ON THE CHILEAN COLOMBIAN MARKETS

    Oct 1, 2019, 00:00

  • PMD3 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN EL SANATORIO FINOCHIETTO DE ARGENTINA

    Oct 1, 2019, 00:00

  • PSU5 ANALISIS COSTE CONSECUENCIA DEL TRASPLANTE DE PROGENITORES HEMATOPOYETICOS DE DONANTE NO RELACIONADO FINANCIADO POR EL FONDO INTANGIBLE SOLIDARIO DE SALUD DEL PERU

    Oct 1, 2019, 00:00

  • PIN15 PUBLIC HEALTH IMPACT OF DENGUE VACCINATION WITH SCREENING IN BRAZIL

    Oct 1, 2019, 00:00

  • PMS13 A ROUTE FOR THE CORRECT DIAGNOSIS OF RHEUMATOID ARTHRITIS - AN OPPORTUNITY TO AVOID MISDIAGNOSIS AND COSTS ASSOCIATED

    Oct 1, 2019, 00:00

  • PND19 RETROSPECTIVE ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT PROFILE AND PATTERNS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    Oct 1, 2019, 00:00

  • PNS30 CHANGES IN THE OWNERSHIP STRUCTURE OF HUNGARIAN HEALTH CARE PROVIDERS

    Oct 1, 2019, 00:00

  • PCN12 COST-EFFECTIVENESS OF PEMBROLIZUMAB COMPARED TO CHEMOTHERAPY AS A TREATMENT FOR PATIENTS WITH PREVIOUSLY TREATED ADVANCED MELANOMA IN CHINA

    Oct 1, 2019, 00:00

  • PUK5 POTENTIALLY INAPPROPRIATE PRESCRIPTIONS OF ANTICHOLINERGIC DRUGS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

    Oct 1, 2019, 00:00

  • PNS1 ¿EXISTE SUFICIENTE EVIDENCIA PARA USAR SUPERVIVENCIA GLOBAL Y CALIDAD DE VIDA COMO DESENLACES CRÍTICOS EN LA TOMA DE DECISIONES EN SALUD?

    Oct 1, 2019, 00:00

  • PCN45 COMPARATIVE ANALYSIS OF BRA CMED, GER G-BA AND FRA HAS ASSESSMENT SCORES FOR ONCOLOGY THERAPIES

    Oct 1, 2019, 00:00

  • PIN22 LOS COSTOS DE LA NEUMONIA ADQUIRIDA EN LA COMUNIDAD Y LA LACTANCIA MATERNA COMO FACTOR DE PROTECCION EN MENORES DE 5 ANHOS EN HOSPITAL PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • CM2 REMOTE MONITORING AFTER THE IMPLANTATION OF A CARDIOVERTER-DEFIBRILLATOR: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2019, 00:00

  • PNS49 EVOLUTION AND RESULTS OF HEALTHCARE PERFORMANCE INDICATORS IN BRAZILIAN SELF-FUNDED HEALTH PLANS

    Oct 1, 2019, 00:00

  • PIN27 USO DE LA REGRESIÓN BETA EN EL ANALISIS DE ASOCIACIÓN ENTRE LOS ÍNDICES EQ-5D-5L, EQ-EVA Y POTENCIALES COVARIABLES EN PACIENTES CON VIH/SIDA EN COLOMBIA

    Oct 1, 2019, 00:00

  • PSU4 BUDGET IMPACT ANALYSIS OF TRICLOSAN-COATED SUTURES FOR SURGICAL SITE INFECTION PREVENTION IN COLOMBIA

    Oct 1, 2019, 00:00

  • EP1 SCHOOL ENVIRONMENT FACTORS ASSOCIATED WITH ADOLESCENTS BMI IN BRAZIL

    Oct 1, 2019, 00:00

  • CL3 ESTUDIO DE EVALUACIÃN ECONÃMICA DEL APÃSITO TRANSPARENTE IMPREGNADO CON CLORHEXIDINA, PARA LA FIJACIÃN DE CATÃTERES CENTRALES BAJO EL CONTEXTO DE LOS HOSPITALES PÃBLICOS DE REPáBLICA DOMINICANA: CASO HOSPITAL DOCENTE PADRE BILLINI, AÃO ...

    Oct 1, 2019, 00:00

  • PCN3 BRAND-BRAND ONCOLOGY COMBINATIONS: HURDLES AND IMPLICATIONS

    Oct 1, 2019, 00:00

  • PMS2 SUCCESSFUL IMPLEMENTATION OF A COMPREHENSIVE CARE PROGRAM IN RHEUMATOID ARTHRITIS WITH SIGNIFICANT COST-SAVINGS FOR THE HEALTH SYSTEM

    Oct 1, 2019, 00:00

  • PIH6 APPROACH TO THE IMPACT OF COVERAGE IN LONG-TERM CONTRACEPTION IN THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY FROM THE PERSPECTIVE OF ISAPRES IN CHILE

    Oct 1, 2019, 00:00

  • PNS24 GASTOS COM MEDICAMENTOS E SEU IMPACTO NA RENDA DAS FAMÍLIAS BRASILEIRAS

    Oct 1, 2019, 00:00

  • CR3 COSTOS DIRECTOS Y CUMPLIMIENTO DE INDICADORES DE CONTROL METABOLICO EN PACIENTES CON DIABETES MELLITUS TIPO 2 EN UN HOSPITAL PUBLICO DE COLOMBIA

    Oct 1, 2019, 00:00

  • PIH10 NATIONWIDE, REAL-WORLD HEALTH INSURANCE TREATMENT COST OF INFERTILITY IN HUNGARY: A COST OF ILLNESS STUDY

    Oct 1, 2019, 00:00

  • PCV7 BUDGET IMPACT OF GLOBAL LONGITUDINAL STRAIN FOR THE EARLY DETECTION OF CARDIOTOXICITY INCORPORATION IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PGI5 BURDEN OF LIVER DISEASE, COLOMBIA 2009-2016

    Oct 1, 2019, 00:00

  • PMS10 NATIONWIDE ANNUAL HEALTH INSURANCE TREATMENT COST OF JUVENILE AND ADOLESCENT IDIOPATHIC SCOLIOSIS IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2019, 00:00

  • MT2 REMOTE MONITORING COMPARED TO CONVENTIONAL FOLLOW-UP FOR PATIENTS WITH HEART FAILURE USING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR: A BUDGET IMPACT ANALYSIS

    Oct 1, 2019, 00:00

  • PIH2 COST-EFFECTIVENESS ANALYSIS OF MEDICINES FOR CONTROLLED OVARIAN STIMULATION IN THE TREATMENT OF INFERTILITY IN PATIENTS WITH AN SUBOPTIMAL OVARIAN RESPONSE IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • HI1 PRELIMINARY COST ANALYSIS OF MISDIAGNOSIS OF RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PMH6 COST-EFFECTIVENESS OF ANTIPSYCHOTIC DRUGS FOR FIRST- AND SECOND-LINE TREATMENT OF SCHIZOPHRENIA IN BRAZIL

    Oct 1, 2019, 00:00

  • PAM6 COMPLEMENTARY AND INTEGRATIVE THERAPIES IN BRAZIL'S UNIFIED HEALTHCARE SYSTEM (SUS) IN 2017: AN UNDERREPORTING CASE

    Oct 1, 2019, 00:00

  • PMU9 ESTABLISHING CHILE RICARTE SOTO LAW REIMBURSEMENT CAP IN THE FACE OF GENERIC COMPETITION

    Oct 1, 2019, 00:00

  • PCV2 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IN ARGENTINA: META-ANALYSIS OF REAL-LIFE DATA

    Oct 1, 2019, 00:00

  • PAM2 GESTION DE SOPORTE NUTRICIONAL EN CUIDADOS INTENSIVOS

    Oct 1, 2019, 00:00

  • PCN15 IMPACTO ECONOMICO DE LAS COMPLICACIONES OSEAS EN PACIENTES CON CANCER DE MAMA METASTASICO (CAMM) EN MEXICO.

    Oct 1, 2019, 00:00

  • PCN20 COSTO EFECTIVIDAD DE LA UTILIZACIÓN DE INHIBIDORES DE PUNTOS DE CONTROL INMUNITARIO (ANTI-PD1/ANTI-CTLA4) Y TERAPIAS DIRIGIDAS (BRAFI/MEKI) EN EL TRATAMIENTO DEL MELANOMA AVANZADO.

    Oct 1, 2019, 00:00

  • PRO1 MEDICAL THERAPY FOR PULMONARY ARTERIAL HYPERTENSION (PAH): AN INDIRECT TREATMENT COMPARISON OF MACITENTAN AND BOSENTAN

    Oct 1, 2019, 00:00

  • PNS20 REPORTS OF SUBSTANDARD MEDICINES: AN ANALYSIS OF THE BRAZILIAN HEALTH SURVEILLANCE NOTIFICATION SYSTEM

    Oct 1, 2019, 00:00

  • PIH8 MODEL TO APPROACH TO THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY IN CHILE: THE IMPACT OF THE FAILURE OF COMPLIANCE OF THE CONTRACEPTIVE METHODS.

    Oct 1, 2019, 00:00

  • PND14 OUT-OF-POCKET EXPENDITURE IN MIGRAINE PATIENTS WITH AND WITHOUT COMORBIDITIES IN CHILE: A HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PCN33 PERTUZUMAB+TRASTUZUMAB TREATMENT ON HER2+ EARLY BREAST CANCER: LONG-TERM REDUCTION OF METASTASIC BREAST CANCER INCIDENCE IN ARGENTINA.

    Oct 1, 2019, 00:00

  • PNS10 THE PENALTY OF MATERNITY FOR LABOR MARKET IN BRAZIL

    Oct 1, 2019, 00:00

  • PCN23 IMPACTO ECONOMICO DE CANCER DE CUELLO UTERINO Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • CV1 CARDIOVASCULAR RISK IN DIABETES PATIENTS MONITORED BY A MOBILE PHONE APP HEALTH CARE PROGRAM IN BRAZIL

    Oct 1, 2019, 00:00

  • PMS17 PATIENT PREFERENCES FOR BIOLOGIC AND BIOSIMILAR OSTEOPOROSIS TREATMENTS IN COLOMBIA: A DISCRETE-CHOICE EXPERIMENT

    Oct 1, 2019, 00:00

  • PMU13 A MULTI-CRITERIA APPROACH TO THE STUDY OF CHRONIC NON-COMMUNICABLE DISEASES IN BRAZIL

    Oct 1, 2019, 00:00

  • PNS7 THE PRICE OF SUBSTITUTE TECHNOLOGIES

    Oct 1, 2019, 00:00

  • PIN10 PUBLIC HEALTH AND ECONOMIC IMPACT OF A HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR FEMALES AGED 9 YEARS IN EL SALVADOR

    Oct 1, 2019, 00:00

  • PSU6 ESTUDIO DE COSTO EFECTIVIDAD ENTRE HEPARINA NO FRACCIONADA Y HEPARINAS DE BAJO PESO MOLECULAR EN PACIENTES SOMETIDOS A ARTROPLASTIA TOTAL DE CADERA ELECTIVA

    Oct 1, 2019, 00:00

  • PMD13 BUNDLE AND RISK SHARING FOR BARIATRIC SURGERY UNDER THE VALUE-BASED CARE (VBC) MODEL: MODEL EFFECTIVENESS AND SUSTAINABILITY AT HOSPITAL ALEMAO OSWALDO CRUZ (HAOC) BASED IN CLINICAL AND ECONOMICAL RESULTS

    Oct 1, 2019, 00:00

  • PCV6 ECONOMIC EVALUATION OF GLOBAL LONGITUDINAL STRAIN IN THE EARLY DETECTION OF CARDIOTOXICITY IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PNS43 ESTIMACIÓN DE UN COSTO DE REFERENCIA PARA EVENTOS HOSPITALARIOS MEDIANTE NORMALIZACIÓN DE DATOS

    Oct 1, 2019, 00:00

  • PBI1 THE VALUE OF ONASEMNOGENE ABEPARVOVEC (AVXS-101) AS A COST-EFFECTIVE GENE REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 IN IMPROVING SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND MOTOR FUNCTION

    Oct 1, 2019, 00:00

  • PCN42 JUDICIALIZATION OF ACCESS TO MEDICINES IN ONCOLOGY: SYSTEMATIZED REVIEW

    Oct 1, 2019, 00:00

  • PMU10 RESULTADOS DE IMPLEMENTACION DE PROGRAMA DE CUIDADOS PALIATIVOS EN UNA ASEGURADORA EN SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN16 COST ESTIMATE ANALYSIS OF ABIRATERONE PLUS PREDNISONE (AAP) AND ENZALUTAMIDE (ENZ) IN INSURED METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS IN ARGENTINA: EVIREPRO DATABASE

    Oct 1, 2019, 00:00

  • PIN28 COSTS OF PERTUSSIS IN BRAZIL: A NINE-YEAR EVALUATION

    Oct 1, 2019, 00:00

  • PBI3 ANÁLISIS DEL COSTO POR RESPONDEDOR DE SECUKINUMAB VS INFLIXIMAB Y ETANERCEPT PARA EL TRATAMIENTO DE LA ARTRITIS PSORIÁSICA DESDE UNA PERSPECTIVA ECUATORIANA

    Oct 1, 2019, 00:00

  • PND6 THE DIRECT COSTS OF MULTIPLE SCLEROSIS IN A GROUP OF COLOMBIAN PATIENTS

    Oct 1, 2019, 00:00

  • PCN14 COSTOS INDIRECTOS DEL CANCER DE MAMA EN COLOMBIA: 1990-2016.

    Oct 1, 2019, 00:00

  • PNS22 DESCRIBING GAPS IN ACCESS TO HEALTHCARE BETWEEN INTERNATIONAL MIGRANTS AND THE CHILEAN-BORN POPULATION

    Oct 1, 2019, 00:00

  • PRO3 DIRECT COSTS OF HEMOPHILIA CARE, THE CASE OF A HEALTH INSURER IN COLOMBIA

    Oct 1, 2019, 00:00

  • PNS12 THE IMPACT OF THE POSTPONEMENT OF MATERNITY ON WOMEN'S INCOME IN BRAZIL

    Oct 1, 2019, 00:00

  • PNS44 COORDENAÇÃO DE CUIDADOS DE SAÚDE ATRAVÉS DE UM APLICATIVO MÓVEL COMO FATOR DE MELHOR RESULTADO CLÍNICO E REDUÇÃO DE CUSTOS

    Oct 1, 2019, 00:00

  • PCN1 EFECTIVIDAD Y SEGURIDAD DEL ESQUEMA DABRAFENIB-TRAMETINIB EN EL TRATAMIENTO DEL MELANOMA AVANZADO/METASTÁSICO IRRESECABLE CON MUTACIÓN BRAF V600: REVISIÓN SISTEMÁTICA DE LA LITERATURA Y METANÁLISIS EN RED

    Oct 1, 2019, 00:00

  • PCV4 ANNUAL HEALTH INSURANCE TREATMENT COST OF HYPERTENSIVE RENAL DISEASE IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2019, 00:00

  • PMD12 HOW MUCH CAN COLOMBIAN HOSPITALS EARN FOR EACH THERAPEUTIC PLASMA EXCHANGE (TPE) PROCEDURE? A MULTI-CENTER, COST COMPARISON STUDY BETWEEN CENTRIFUGAL AND MEMBRANE SYSTEMS

    Oct 1, 2019, 00:00

  • PSY8 CURRENT PRACTICE AND RESOURCE USE ASSOCIATED WITH TREATMENT OF VENOUS THROMBOEMBOLISM DISEASE IN SOCIAL SECURITY SECTOR OF ARGENTINA

    Oct 1, 2019, 00:00

  • PIN11 COST-EFFECTIVENESS OF INTERFERON-GAMMA RELEASE ASSAY COMPARED TO TUBERCULIN SKIN TEST FOR DETECTION OF LATENT TUBERCULOSIS IN PATIENTS WITH RENAL FAILURE UNDERGOING HEMODIALYSIS

    Oct 1, 2019, 00:00

  • PDB3 PHARMACIST LED INTERVENTION ON HEALTH-RELATED QUALITY OF LIFE OF DIABETIC PATIENTS AND ITS RELATIONSHIP WITH PATIENT DEMOGRAPHICS ON EQ-5D DOMAINS AND VAS SCORE

    Oct 1, 2019, 00:00

  • PRO13 IMPACT OF CAREGIVER EXPERIENCE AND HRQOL IN LATER-ONSET SPINAL MUSCULAR ATROPHY (SMA): RESULTS FROM THE PHASE 3 CHERISH TRIAL

    Oct 1, 2019, 00:00

  • PMS11 EPIDEMIOLOGY, USE OF RESOURCES AND COST OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN ARGENTINA: AN EXTENSIVE REVIEW WITH EXPERT ELICITATION

    Oct 1, 2019, 00:00

  • PAM5 AVALIAÇÃO DO USO DA OZONIOTERAPIA EM PACIENTES COM DOR LOMBAR: UM ESTUDO DE METANALISE

    Oct 1, 2019, 00:00

  • PMS1 SUSTAINED REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS: EVIDENCE FROM A COHORT FOLLOWED-UP AT A CENTER OF EXCELLENCE IN COLOMBIA

    Oct 1, 2019, 00:00

  • PRS6 LA EVOLUCIÓN DE LA CARGA DE ENFERMEDAD DE LA FIBROSIS PULMONAR IDIOPÁTICA EN LA POBLACIÓN ECUATORIANA DE 2011 A 2017

    Oct 1, 2019, 00:00

  • PCN6 COSTO-EFECTIVIDAD DEL ESQUEMA DABRAFENIB EN COMBINACIÓN CON TRAMETINIB EN COMPARACIÓN CON OTRAS TERAPIAS DIRIGIDAS, INMUNOTERAPIA Y DACARBAZINA PARA EL TRATAMIENTO DE MELANOMA IRRESECABLE O METASTÁSICO CON MUTACIÓN BRAFV600 EN COLOMBIA ...

    Oct 1, 2019, 00:00

  • PRO4 COST-EFFECTIVENESS ANALYSIS OF AN INTEGRATED EXTRACORPOREAL PHOTOPHERESIS SYSTEM VERSUS SELECTED TREATMENTS FOR REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE

    Oct 1, 2019, 00:00

  • PCN18 ANTINEOPLASICOS ORAIS NA PRIMEIRA LINHA DE TRATAMENTO DE LEUCEMIA MIELOIDE CRONICA: UMA ANALISE DE CUSTO

    Oct 1, 2019, 00:00

  • PGI1 EFFECTS OF FECAL MICROBIOTA TRANSPLANTATION IN INFLAMMATORY BOWEL DISEASE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2019, 00:00

  • PMU11 COMPARATIVE ASSESSMENT OF HTA OUTCOMES IN BRAZIL, CANADA AND THE UNITED KINGDOM

    Oct 1, 2019, 00:00

  • PRS2 COST ANALYSIS FOR THE TREATMENT OF SEVERE UNCONTROLLED BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PMU8 DIFERENCIAS EN LA MORTALIDAD SEGUN LUGAR DE OCURRENCIA Y REGIMEN DE SALUD EN EL CARIBE COLOMBIANO, 2016

    Oct 1, 2019, 00:00

  • PNS14 EVIDENCE ON THE POSTPONEMENT OF MATERNITY IN BRAZIL

    Oct 1, 2019, 00:00

  • PMD4 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN EL SISTEMA DE SALUD PUBLICO DE MENDOZA, ARGENTINA

    Oct 1, 2019, 00:00

  • CN2 EVALUACIÓN DE COSTO-EFECTIVIDAD DE LA ENZALUTAMIDA (ENZA) FRENTE A LA ABIRATERONA (ABI) PARA EL TRATAMIENTO DE PACIENTES CON CÁNCER DE PRÓSTATA RESISTENTE A LA CASTRACIÓN METASTÁSICO (CPRCM) ANTES DEL USO DE DOCETAXEL EN EL INSTITUTO ME ...

    Oct 1, 2019, 00:00

  • PCN28 OVARIAN CANCER MORTALITY TREND IN BRAZIL: A LINEAR REGRESSION ANALYSIS BETWEEN 1981 AND 2016

    Oct 1, 2019, 00:00

  • PBI10 REAL WORLD SWITCHING PATTERNS OF ETANERCEPT ORIGINAL AND BIOSIMILAR IN GERMANY

    Oct 1, 2019, 00:00

  • PBI4 COMPORTAMIENTO DE USO DE TERAPIA BIOLÓGICA Y COSTOS ASOCIADOS DE UN PROGRAMA DE ATENCIÓN EN PACIENTES CON DIAGNASTICO DE ARTRITIS REUMATOIDE EN COLOMBIA

    Oct 1, 2019, 00:00

  • PIN6 O IMPACTO ECONOMICO NA AVALIACAO DO INFECTOLOGISTA NO PROGRAMA DE GESTAO CLINICA DO USO DE ANTIMICROBIANOS EM HOSPITAL PRIVADO DE FORTALEZA- CE, BRASIL

    Oct 1, 2019, 00:00

  • CL2 EFFECTIVENESS OF TREATMENT WITH DIRECT-ACTING ANTIVIRALS IN THE COLOMBIAN POPULATION WITH CHRONIC HEPATITIS C

    Oct 1, 2019, 00:00

  • PDB14 LOVASTATIN, ATORVASTATIN AND ROSUVASTATIN CONSUMPTION IN COLOMBIA FROM 2010 TO 2017

    Oct 1, 2019, 00:00

  • TP1 TRATAMIENTO DEL CANCER DE MAMA ESTADIO IV, ANÃLISIS DE LOS DATOS REPORTADOS A LA CUENTA DE ALTO COSTO. COLOMBIA 2017

    Oct 1, 2019, 00:00

  • PMH7 COST-EFFECTIVENESS AND INCORPORATION PRICE OF ARIPIPRAZOLE FOR SCHIZOPHRENIA IN BRAZIL: A SUBSTITUTE TECHNOLOGY APPROACH

    Oct 1, 2019, 00:00

  • PSY5 QUALITY OF LIFE OF INDIVIDUALS WITH PSORIASIS IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PMU7 POPULATION HEALTH IMPACT MODEL

    Oct 1, 2019, 00:00

  • PMU14 USO DEL EQ-5D EN MEXICO

    Oct 1, 2019, 00:00

  • PIT6 SELF-INFLICTED LESIONS IN BRAZIL: A DESCRIPTIVE ANALYSIS BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PCV15 GOOD PRACTICES ASSESSMENT FOR CARDIAC SURGERIES: A REAL WORLD ANALYSIS

    Oct 1, 2019, 00:00

  • PMS5 USE OF AN ALGORITHM WITHIN A MULTIDISCIPLINARY CONSULTATION FOR THE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS CANDIDATES FOR BIOLOGICAL THERAPY - A STRATEGY FOR OPTIMIZING COSTS

    Oct 1, 2019, 00:00

  • PIN8 ANALISE ECONOMICA DE CUSTOS DE TRATAMENTO DE INFECCOES POR MICROORGANISMOS GRAM-POSITIVOS RESISTENTES: STAPHYLOCOCCUS AUREUS RESISTENTE A METICILINA (MRSA) E ENTEROCOCCUS SPP RESISTENTES A VANCOMICINA (VRE)

    Oct 1, 2019, 00:00

  • PDB6 COSTO DE OBESIDAD Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PDB11 BUDGET IMPACT ANALYSIS OF SWITCHING FROM ALOGLIPTIN TO VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES

    Oct 1, 2019, 00:00

  • PMS18 COST-ANALYSIS OF TREATMENT FOR MODERATE AND SEVERE RHEUMATOID ARTHRITIS IN A SPECIALIZED RHEUMATOLOGY CENTER

    Oct 1, 2019, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • »